Get started
Author

Sara C. Hanna

Observed names: Hanna, Sara, Hanna, Sara C., Sara C Hanna
OpenAlex ID: A5022009136
Regulation of endocytosis via the oxygen-sensing pathway
2009 · Yi Wang, Olga Roche, et al. · Nature Medicine · 192
HIF1α and HIF2α independently activate SRC to promote melanoma metastases
2013 · Sara C. Hanna, Bhavani Krishnan, et al. · Journal of Clinical Investigation · 147
PDF
mTOR pathway in renal cell carcinoma
2008 · Sara C Hanna, Samuel A Heathcote, et al. · Expert Review of Anticancer Therapy · 54
IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2015 · Craig C. Carson, Stergios J. Moschos, et al. · Clinical Cancer Research · 16
Supplementary Tables 3 and 4 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Table 1 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Figure 2 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Figure 1 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Table 2 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Table 6 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Table 5 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Figure legends from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Data from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Data from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Figure legends from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Table 1 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Table 6 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
Supplementary Table 5 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Figure 1 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Table 2 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Figure 2 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
PDF
Supplementary Tables 3 and 4 from IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2023 · Craig C. Carson, Stergios J. Moschos, et al.
IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
2020 · Parrish, Eloise, Hopkinson, Dennis A., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
HIF1α and HIF2α independently activate SRC to promote melanoma invasion and metastasis
2019 · Hanna, Sara · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Works count: 24
Citation count: 409
H-index: 4
I10-index: 4
Year
Topic
Type